We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Optimization of CTCA Protocols Offers Significant Radiation Dose Reduction

By HospiMedica International staff writers
Posted on 02 Jun 2010
Optimization of protocols during computed tomography coronary angiography (CTCA) using prospective electrocardiogram (ECG) gating and breast shields can reduce the radiation dose delivered to the female breast by more than 80%.

CTCA is a common, noninvasive procedure that is used to evaluate the coronary arteries. More...
Prospective ECG gating is an imaging technique that allows radiologists to scan only during a certain phase of the heart beat cycle. Breast shields are placed over the chest during a CT exam to block out primary X-ray beams, which are responsible for most of the breast radiation during a CT study.

"As cardiac CTCA has significant potential for the noninvasive imaging of coronary artery disease, its utilization is continuously increased, particularly among young women,” said Sobhi Abadi, M.D., lead author of the study. "Therefore, the radiation dose delivered to the female's breasts should be addressed.”

Researchers from the University Health Network (Toronto, Canada), scanned an adult female phantom using eight different CTCA protocols. "The highest breast dose (82.9 mGy) was associated with using retrospective ECG gating. The lowest breast dose (15.2 mGy) was achieved with prospective gating with narrow exposure window, resulting in an 82% reduction in breast dose. The use of surface breast shields resulted in an additional 38% reduction in breast dose,” said Dr. Abadi.

The study was presented May 4, 2010, at the American Roentgen Ray Society (ARRS) 2010 annual meeting held in San Diego, CA,USA. "All use of ionizing radiation requires constant vigilance to ensure appropriate utilization and this is certainly true for CTCA,” Dr. Abadi concluded. "Significant reductions in radiation dose will reduce the statistical likelihood of causing genetic damage and long-term risk of adverse results.”

Related Links:

University Health Network




New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.